Multiple Sclerosis Management: Opportunities for the Healthcare Team to Improve Outcomes with Current and Emerging Treatment Options
Slide Lecture with Audio
Sponsored by North American Center for Continuing Medical Education, LLC
Presenters/Q&A Cohosts
Howard L. Zwibel, MD
Neurologic Consultants Comprehensive
Multiple Sclerosis Center
Founding Medical Director Emeritus
Coral Gables, Florida
Kathleen Costello, MS, ANP-BC, MSCN
Research Associate/Nurse Practitioner
Johns Hopkins MS Center
Johns Hopkins Medicine
Department of Neuroimmunology
Baltimore, Maryland
Learning Objectives
After completing this activity, participants should be able to:
- Describe the long-term safety and efficacy of current and emerging treatment options for patients with newly diagnosed and relapsed multiple sclerosis (MS)
- Compare and contrast the risks and benefits of immunomodulators and immunosuppressants in MS management
- Explain the role of advanced imaging results in showing the impact of MS therapy on brain atrophy and neuronal preservation
- Apply knowledge gained on safe and effective MS management options to optimize patient quality of life and reduce disability
Target Audience
This activity is designed for nurse practitioners, nurses, physician assistants, and pharmacists.
Activity Overview
This on-demand slide lecture is available with html slides and the presentation transcript.
To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
There is no fee associated with this activity.
This educational activity is a knowledge-based activity.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this activity.
Release Date: April 30, 2010
Expiration Date: April 30, 2011
Estimated time to complete: 1 hour
For questions regarding this activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
CME Accreditation (Accepted for Physician Assistants)
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
AANP Accreditation
This program is approved for 1.0 contact hours of continuing education by the American Academy of Nurse Practitioners. Program ID 1002028.
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
CNE Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This continuing nursing education activity was approved for 1 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.
CPE Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-10-011-H01-P)
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.
Independent Clinical Reviewer: Darin T. Okuda, MD, Assistant Clinical Professor of Neurology, UCSF Multiple Sclerosis Center, San Francisco, California
International Organization of Multiple Sclerosis Nurses (IOMSN) has reviewed this project that was developed by North American Center for Continuing Medical Education as a resource for nurse practitioners and physician assistants. IOMSN has concluded that this project is fair balanced and accurate and is valid for educational purposes.
Planning Committee
The planning committee comprises Kathleen Costello, MS, ANP-BC, MSCN, Darin T. Okuda, MD, Howard Zwibel, MD; Kristin Ciszeski, Mary Johnson, Mike Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Ms. Costello: Consultant—Acorda Therapeutics, Biogen Idec, EMD Serono, Inc, Novartis; Promotional speakers bureau—Biogen Idec, EMD Serono, Inc, Teva Neuroscience
Dr. Okuda: Grant/research support—Pfizer, Inc, EMD Serono, Inc
Dr. Zwibel: Consultant—Acorda Therapeutics, Teva Neuroscience; Promotional speakers bureau—Teva Neuroscience
Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, ViroPharma, Inc, Vertex Pharmaceuticals
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty has disclosed that the following off-label/unapproved use(s) of drugs and/or devices will be discussed: investigational agents (fingolimod, cladribine, laquinimod, teriflunomide, dimethyl fumarate, alemtuzumab, rituximab/ocrelizumab, and daclizumab) in the treatment of MS.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from Teva Neuroscience.
